Back to News
Market Impact: 0.2

Canaccord Genuity Upgrades Progyny (PGNY)

CF.TOPGNY
Analyst EstimatesAnalyst InsightsCompany FundamentalsHealthcare & Biotech

Canaccord Genuity upgraded Progyny (NasdaqGS:PGNY) from Hold to Buy on May 19, 2026, with the analyst price forecast implying 16.83% upside. The note is modestly positive for the stock and reflects improved analyst sentiment rather than new operating results.

Analysis

Canaccord Genuity upgraded Progyny (NasdaqGS:PGNY) from Hold to Buy on May 19, 2026, with the analyst price forecast implying 16.83% upside. The note is modestly positive for the stock and reflects improved analyst sentiment rather than new operating results.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

CF.TO0.00
PGNY0.45